Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fraguas

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Pediatrics|October 6, 2019
Dietary Interventions for Autism Spectrum Disorder: A Meta-analysisDavid Fraguas, Covadonga M Díaz-Caneja, Laura Pina-Camacho, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2019
Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal modelMarta Casquero-Veiga, David García-García, Karina S MacDowell, et al.
Schizophrenia Research|February 28, 2012
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal studyDavid Fraguas, Ana Gonzalez-Pinto, Juan Antonio Micó, et al.
Revista De Psiquiatria Y Salud Mental|August 3, 2012
[Eligibility of schizophrenia inpatients to participate in clinical trials]Eliseo Iniesta, Marta Lucas, Juana Ruiz, et al.
Journal of Psychiatric Research|July 9, 2026
Validation of the SPF-10: A new scale for assessing self-perceived functioning in schizophrenia. The VALFASS studyM Paz Garcia Portilla, Pilar Sierra San Miguel, Iluminada Corripio, et al.
Molecular Autism|August 28, 2020
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysisSpyridon Siafis, Oğulcan Çıray, Johannes Schneider-Thoma, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 3, 2014
Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patientsCelso Arango, Miriam Giráldez, Jessica Merchán-Naranjo, et al.
Medicina Clinica|April 15, 2008
[Factors related to the length of the corrected QT interval in patients treated with antipsychotics]David Fraguas Herráez, Paula Laita de Roda, Guillermo González Balmaseda, et al.
International Journal of Psychiatry in Clinical Practice|July 6, 2022
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practiceDavid Fraguas, David Almenta Gallego, Sergio Arques-Egea, et al.
Journal of Clinical Medicine|September 10, 2021
Fronto-Parietal Gray Matter Volume Loss Is Associated with Decreased Working Memory Performance in Adolescents with a First Episode of PsychosisMarta Rapado-Castro, Mara Villar-Arenzana, Joost Janssen, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Pediatrics|October 6, 2019
Dietary Interventions for Autism Spectrum Disorder: A Meta-analysisDavid Fraguas, Covadonga M Díaz-Caneja, Laura Pina-Camacho, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2019
Risperidone administered during adolescence induced metabolic, anatomical and inflammatory/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal modelMarta Casquero-Veiga, David García-García, Karina S MacDowell, et al.
Schizophrenia Research|February 28, 2012
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal studyDavid Fraguas, Ana Gonzalez-Pinto, Juan Antonio Micó, et al.
Revista De Psiquiatria Y Salud Mental|August 3, 2012
[Eligibility of schizophrenia inpatients to participate in clinical trials]Eliseo Iniesta, Marta Lucas, Juana Ruiz, et al.
Journal of Psychiatric Research|July 9, 2026
Validation of the SPF-10: A new scale for assessing self-perceived functioning in schizophrenia. The VALFASS studyM Paz Garcia Portilla, Pilar Sierra San Miguel, Iluminada Corripio, et al.
Molecular Autism|August 28, 2020
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysisSpyridon Siafis, Oğulcan Çıray, Johannes Schneider-Thoma, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 3, 2014
Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patientsCelso Arango, Miriam Giráldez, Jessica Merchán-Naranjo, et al.
Medicina Clinica|April 15, 2008
[Factors related to the length of the corrected QT interval in patients treated with antipsychotics]David Fraguas Herráez, Paula Laita de Roda, Guillermo González Balmaseda, et al.
International Journal of Psychiatry in Clinical Practice|July 6, 2022
Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practiceDavid Fraguas, David Almenta Gallego, Sergio Arques-Egea, et al.
Journal of Clinical Medicine|September 10, 2021
Fronto-Parietal Gray Matter Volume Loss Is Associated with Decreased Working Memory Performance in Adolescents with a First Episode of PsychosisMarta Rapado-Castro, Mara Villar-Arenzana, Joost Janssen, et al.
Pageof 8